Physician profile
Kenneth W Rabe
NPI 1538332341
$3,266.99
in general payments reported to CMS, 2019-2025
31 companies · none reported in 2025
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $731 · 2020: $843 · 2021: $1,644 · 2022: $49.41.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $862.62 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $505.69 | 2019-2021 | |
| Saol Therapeutics INC. | $226.04 | 2021 | |
| Medtronic, INC. | $169.75 | 2021 | |
| Abbvie INC. | $157.25 | 2021 | |
| Biodelivery Sciences International, INC. | $151.01 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $140.79 | 2019-2021 | |
| Allergan, INC. | $138.90 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $116.98 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $94.86 | 2019-2021 | |
| Medtronic USA, INC. | $86.83 | 2019-2020 | |
| Amgen INC. | $85.58 | 2020-2021 | |
| Nalu Medical, INC. | $79.99 | 2021-2022 | |
| Scilex Pharmaceuticals INC. | $77.96 | 2019-2021 | |
| Pacira Therapeutics, INC. | $63.77 | 2019-2021 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shionogi INC | $49.76 | 2019 | |
| Eisai INC. | $36.16 | 2021 | |
| Assertio Therapeutics, INC. | $25.78 | 2019-2020 | |
| Pfizer INC. | $23.30 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $21.36 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $18.84 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $16.37 | 2021 | |
| Ipsen Biopharmaceuticals, INC | $15.59 | 2020 | |
| Bioventus LLC | $15.51 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $14.12 | 2022 | |
| Painteq LLC | $13.22 | 2021 | |
| Ibsa Pharma INC. | $12.09 | 2021 | |
| Daiichi Sankyo INC. | $12.03 | 2019 | |
| Lilly USA, LLC | $11.99 | 2022 | |
| Mdd US Operations, LLC | $11.99 | 2019 | |
| Horizon Therapeutics Plc | $10.86 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Rabe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.